share_log

BRIEF-FDA Approves Immix Biopharma Rare Pediatric Disease Designation For IMX-110

reuters ·  Jan 3, 2022 13:26

Jan 3 (Reuters) - $Immix Biopharma(IMMX.US)$:

* U.S. FOOD AND DRUG ADMINISTRATION APPROVES IMMIX BIOPHARMA RARE PEDIATRIC DISEASE DESIGNATION FOR IMX-110 AS A TREATMENT FOR LIFE-THREATENING PEDIATRIC CANCER IN CHILDREN

* IMMIX BIOPHARMA - RPDD QUALIFIES CO TO RECEIVE FAST TRACK REVIEW, & A PRIORITY REVIEW VOUCHER AT TIME OF MARKETING APPROVAL OF IMX-110

Source text for Eikon:  ID:nGNX4Gc68g  Further company coverage:  IMMX.O

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 1195

Recommended

Write a comment